Client News

es Last Patient Out for Phase 2/3 COVID-19 Study of Oral Opaganib RedHill Biopharma Announces Last Patient Out for Phase 2/3 COVID-19 Study of Oral Opaganib

Marinomed Biotech AG announces grant of Chinese Patent covering the proprietary Marinosolv technology to generate aqueous solutions from insoluble compounds

Avisa Diagnostics to Participate at Upcoming Investor Events

AiCuris starts its first pivotal clinical phase 3 trial with pritelivir for the treatment of herpes simplex virus infections in immunocompromised subjects based on efficacy and safety data from a phase 2 trial

Diaccurate introduces its world-leading scientific advisory board

APEIRON Biologics launches next clinical trial with innovative cancer therapy APN401

Marinomed Biotech AG expands distribution of Corona virus blocker Carragelose into Brazil and Mexico

Marinomed Biotech AG Reports Encouraging Topline Data for Phase II Clinical Trial of Tacrosolv in Allergic Rhinoconjunctivitis

Rentschler Biopharma expands production of highly complex antibodies at German site

XPhyto Supplies 10 Test Centers in Berlin with 25-minute COVID-19 PCR Test